FDA Approved: LEVETIRACETAM — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved an original ANDA for levetiracetam from Mylan Institutional LLC, enabling a generic version of the anticonvulsant to reach the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Tonic-clonic Seizures
• Myoclonic Seizures
• Partial-onset Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)